1,440 de novo miniprotein binders (50 to 120 residues) against 16 targets, designed by two Claude models operating as autonomous protein-design agents (Mythos Preview, 900 designs; Opus 4.8, 540 designs) and characterized at two contract research organizations, Adaptyv Bio (cell-free expression; SPR/BLI kinetics with the design immobilized) and Twist Bioscience (Fc-fusion expression; capture SPR with a six-point antigen… See the full description on the dataset page:
https://huggingface.co/datasets/dfzj2026/claude-protein-binder-design.
